TW349995B - Monoclonal anti-IgM antibody conjugated to gelonin - Google Patents
Monoclonal anti-IgM antibody conjugated to geloninInfo
- Publication number
- TW349995B TW349995B TW080103007A TW80103007A TW349995B TW 349995 B TW349995 B TW 349995B TW 080103007 A TW080103007 A TW 080103007A TW 80103007 A TW80103007 A TW 80103007A TW 349995 B TW349995 B TW 349995B
- Authority
- TW
- Taiwan
- Prior art keywords
- gelonin
- monoclonal
- igm antibody
- monoclonal anti
- antibody conjugated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6873—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting an immunoglobulin; the antibody being an anti-idiotypic antibody
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51597490A | 1990-04-27 | 1990-04-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW349995B true TW349995B (en) | 1999-01-11 |
Family
ID=24053580
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW080103007A TW349995B (en) | 1990-04-27 | 1991-04-17 | Monoclonal anti-IgM antibody conjugated to gelonin |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0538267A4 (zh) |
| JP (1) | JPH06504424A (zh) |
| CN (1) | CN1057072A (zh) |
| CA (1) | CA2079901A1 (zh) |
| IE (1) | IE911172A1 (zh) |
| IL (1) | IL97827A0 (zh) |
| NZ (1) | NZ237784A (zh) |
| PT (1) | PT97482B (zh) |
| RU (1) | RU2105062C1 (zh) |
| TW (1) | TW349995B (zh) |
| WO (1) | WO1991017257A1 (zh) |
| ZA (1) | ZA912695B (zh) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2322562B1 (en) | 2008-09-05 | 2016-03-30 | Sekisui Medical Co., Ltd. | Monoclonal antibody, and immunoassay using same |
| CN108384761B (zh) * | 2018-03-30 | 2020-08-11 | 四川迈克生物新材料技术有限公司 | 抗人IgM单克隆抗体、其杂交瘤细胞株及应用 |
| WO2023088443A1 (zh) * | 2021-11-20 | 2023-05-25 | 东莞市朋志生物科技有限公司 | 一种抗人IgM抗体及其制备方法和用途 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4792447A (en) * | 1981-07-23 | 1988-12-20 | Board Of Regents, The University Of Texas System | Anti-immunoglobulin toxin conjugates useful in the treatment of B cell tumors |
| WO1992007574A1 (en) * | 1990-10-25 | 1992-05-14 | Tanox Biosystems, Inc. | Glycoproteins associated with membrane-bound immunoglobulins as antibody targets on b cells |
-
1991
- 1991-04-08 IE IE117291A patent/IE911172A1/en unknown
- 1991-04-10 NZ NZ237784A patent/NZ237784A/en unknown
- 1991-04-11 IL IL97827A patent/IL97827A0/xx unknown
- 1991-04-11 ZA ZA912695A patent/ZA912695B/xx unknown
- 1991-04-17 TW TW080103007A patent/TW349995B/zh active
- 1991-04-24 RU RU92016351A patent/RU2105062C1/ru active
- 1991-04-24 EP EP19910909436 patent/EP0538267A4/en not_active Withdrawn
- 1991-04-24 WO PCT/US1991/002822 patent/WO1991017257A1/en not_active Application Discontinuation
- 1991-04-24 JP JP3509144A patent/JPH06504424A/ja active Pending
- 1991-04-24 CA CA002079901A patent/CA2079901A1/en not_active Abandoned
- 1991-04-26 PT PT97482A patent/PT97482B/pt not_active IP Right Cessation
- 1991-04-27 CN CN91102913A patent/CN1057072A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA2079901A1 (en) | 1991-10-28 |
| NZ237784A (en) | 1992-09-25 |
| EP0538267A1 (en) | 1993-04-28 |
| ZA912695B (en) | 1993-02-24 |
| PT97482A (pt) | 1992-01-31 |
| PT97482B (pt) | 1998-08-31 |
| IE911172A1 (en) | 1991-11-06 |
| AU7866491A (en) | 1991-11-27 |
| IL97827A0 (en) | 1992-06-21 |
| AU650659B2 (en) | 1994-06-30 |
| CN1057072A (zh) | 1991-12-18 |
| RU2105062C1 (ru) | 1998-02-20 |
| WO1991017257A1 (en) | 1991-11-14 |
| JPH06504424A (ja) | 1994-05-26 |
| EP0538267A4 (en) | 1994-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2106195T3 (es) | Anticuerpo igg aglicosilado anti cd3. | |
| DE69233051D1 (de) | Antikörper gegen CD40-L | |
| BR9604955A (pt) | Polipeptídeos alterados com semi-vida aumentada | |
| MY104946A (en) | Antigen antibody conjugate. | |
| DE69630313D1 (de) | Mit monoklonalem antikörper anti-her2 induzierte apoptosis | |
| ZA946767B (en) | Monocional antibodies having property of causing apoptosis. | |
| ES2129487T3 (es) | Peptidos sinteticos, anticuerpos dirigidos contra ellos y su utilizacion. | |
| ZA874558B (en) | Monoclonal antibodies to unreduced,nonenzymatically-glycated proteins | |
| AU7657387A (en) | Apoprotein b-100 specific monoclonal antibodies | |
| TW349995B (en) | Monoclonal anti-IgM antibody conjugated to gelonin | |
| AU2707992A (en) | Monoclonal antibodies to hepatitis c virus | |
| AU623753B2 (en) | Anti-human sperm antibody, and its production | |
| DE3850993D1 (de) | Monoklonaler Antikörper spezifisch gegen humane Pankreas-Phospholipase-A2. | |
| ES2061973T3 (es) | Anticuerpos monoclonales que reconocen la region n-terminal de polipeptido natriuretico auricular, su preparacion y uso. | |
| DK329789D0 (da) | Monoklonalt antistof | |
| AU4773085A (en) | Anti-urokinase monoclonal antibody; its production and use | |
| ATE263784T1 (de) | Anti-megakaryozyten monoklonaler antikörper 97a6 | |
| EP0089771A3 (en) | Atcc hb8116 and its monoclonal anti-h-y antibody, hyclonalan | |
| EP0370768A3 (en) | Monoclonal antibody for the antigen specific to carcinoma of the thyroid | |
| DE69118827D1 (de) | Antikörper gegen Hamsterimmunglobulinen | |
| BG51817A1 (en) | Hydrydome cellular line, secretting monoclonal antibody against tumourconnected antigen | |
| ES1008502U (es) | Anzuelo mejorado. |